Cover Image

Editorial: Biologically active products as therapeutic options for the treatment of cardiovascular diseases related to liver injury

Saved in:

Bibliographic Details
Main Authors:	Arquimedes Gasparotto Junior (Author), Francislaine Aparecida dos Reis Lívero (Author), Alexandra Acco (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats
by: Pablo Alvarez Auth, et al.
Published: (2022)

Pharmacological Advances for Treatment in Hypertension
by: Arquimedes Gasparotto Junior
Published: (2023)

Editorial: New Therapeutic Options for Rare Diseases
by: Sascha Meyer, et al.
Published: (2022)

NO-cGMP-K<sup>+</sup> Channels Pathways Participate in the Antihypertensive Effects of <i>Attalea phalerata</i> Martius ex Spreng Oil-Loaded Nanocapsules
by: Maria Medina de Azevedo, et al.
Published: (2024)

Editorial: Therapeutic strategies for drug-induced liver injury: Review of the current literature
by: Mercedes Robles-Díaz, et al.
Published: (2022)

Effects of <i>Baccharis dracunculifolia</i> DC on an Innovative Animal Model of Cardiometabolic Syndrome
by: Gustavo Ratti da Silva, et al.
Published: (2024)

Editorial: Endocrine Diseases of Newborn: Epidemiology, Pathogenesis, Therapeutic Options and Outcome
by: Paula Caroline Midgley, et al.
Published: (2021)

Editorial: Circadian biology, cardiovascular function and disease
by: Nelson Chong, et al.
Published: (2023)

Editorial: Plant products for antiviral therapeutics
by: Anirban Mandal, et al.
Published: (2022)

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
by: Vajro Pietro, et al.
Published: (2012)

The Influence of Estrogens on the Biological and Therapeutic Actions of Growth Hormone in the Liver
by: Leandro Fernández-Pérez, et al.
Published: (2012)

IFN-αα induced psoriatic arthritis and HCV-related liver cirrhosis. Therapeutic options and patient's opinion
by: M. Piga, et al.
Published: (2011)

Sporotrichosis: An Overview and Therapeutic Options
by: Vikram K. Mahajan
Published: (2014)

Endometriosis-associated pain and new therapeutic options: A review
by: Maria I. Yarmolinskaya, et al.
Published: (2023)

Editorial: Diabetes and cardiovascular disease: new therapeutic interventions
by: Maria Consiglia Trotta, et al.
Published: (2024)

Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis
by: Cuiling Liu, et al.
Published: (2024)

The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy
by: Yunfei Yin, et al.
Published: (2023)

Therapeutic options for advanced thyroid cancer
by: Apoorva Jayarangaiah, et al.
Published: (2019)

Therapeutic options at the Neonatal Pathology Ward
by: Monika Joanna Stecko, et al.
Published: (2020)

Therapeutic options in the treatment of supernumerary teeth
by: Janković Svjetlana, et al.
Published: (2022)

New therapeutic options in the treatment of odontomas
by: Bálint Trimmel, et al.
Published: (2021)

New therapeutic options in migraine treatment
by: Aleksandra Kłos, et al.
Published: (2024)

Therapeutic Options Used for Myasthenia Gravis
by: J Gordon Millichap
Published: (2011)

Therapeutic Options for Childhood Absence Epilepsy
by: Victoria Elisa Rinaldi, et al.
Published: (2021)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
by: Cheng Xue Qin, et al.
Published: (2020)

Biological treatment options for severe asthma in Poland
by: Maciej Superson, et al.
Published: (2024)

Progress in the treatment of drug-induced liver injury with natural products
by: Yuan-kai Sun, et al.
Published: (2022)

Editorial of Special Column on Drug- and Chemical-Induced Liver Injury
by: James Luyendyk, et al.
Published: (2021)

Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation
by: Hongjuan Lu, et al.
Published: (2021)

Editorial: Therapeutic potential of natural products in oxidative and metabolic diseases
by: Aliyu Muhammad, et al.
Published: (2024)

Therapeutic options for women with infertility before IVF
by: Н. О. Данкович, et al.
Published: (2017)

Dermabrasion in exogenous ochronosis: a therapeutic option
by: Cintia Navarro Lamas, et al.
Published: (2023)

Trifarotene: A Novel Therapeutic Option for Acne
by: Piyu Parth Naik
Published: (2022)

Aromatase inhibitors in men: effects and therapeutic options
by: de Jong Frank H, et al.
Published: (2011)

COVID-19 Therapeutic Options Under Investigation
by: Malak Kaddoura, et al.
Published: (2020)

Topical Therapeutic Options in Corneal Neuropathic Pain
by: Jeremy Nortey, et al.
Published: (2022)

Lysosomal Acid Lipase Deficiency: Therapeutic Options
by: Pastores GM, et al.
Published: (2020)

Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
by: Tesfaye BA, et al.
Published: (2021)

Curcumin as a Therapeutic Option in Retinal Diseases
by: Daniel López-Malo, et al.
Published: (2020)

Therapeutic options for ampullary carcinomas. A review
by: Dileep Kumar Reddy Regalla, et al.
Published: (2019)